NCT05116215View on ClinicalTrials.gov

To Evaluate the Safety of Treating Autoimmune Diseases With Molecular Hydrogen Supplement

PHASE1UnknownINTERVENTIONAL

Enrollment

27

Participants

Timeline

Start Date

August 13, 2021

Primary Completion Date

August 12, 2022

Study Completion Date

August 12, 2022

Conditions

Autoimmune Diseases

Interventions

DRUG

Hydrogen

Hydrogen supplement

Trial Locations (1)

Unknown

RECRUITING

Tri-Service General Hospital, Taipei

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Tri-Service General Hospital

OTHER

lead

HoHo Biotech

INDUSTRY